Dipna Pharmachem share news and announcements

BSE: 543594Pharmaceuticals & BiotechnologySmall Cap

₹3.89₹0.04 (1.02%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹3.93.

52-week range of traded prices to 23 Oct 2026

₹3.89Low, 8 Oct 2026₹20.50High, 30 Oct 2025

Market cap: ₹10 Cr3,953rd largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 18,000

Dipna Pharmachem share news and announcements

194 announcements, routine notices left out, newest first. Page 3 of 4.

Apr 2024
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Sevantilal Shah (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Financial Advisors LLP (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Shah (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Financial Advisors LLP (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Financial Advisors LLP (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemal Shah (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemal Shah (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Shah (opens in a new tab)
- 18 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Shah (opens in a new tab)
- 8 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 26/04/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 .... (opens in a new tab)
- 6 Apr · Corporate action
  Intimation of Trading Approval for Rights Issue (opens in a new tab)
- 2 Apr · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Sales Order Of Rs. 12.75 Crores
  Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 received sales order of Rs. 12.75 Crores (opens in a new tab)
Mar 2024
- 29 Mar · Board meeting
  Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 ("the Regulations"), we hereby inform you that the Rights Issue Committee of Directors .... (opens in a new tab)
- 19 Mar · Board meeting
  Meeting on 19 Mar 2024
- 19 Mar · Board meeting
  With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 19th March, 2024 the date of closure .... (opens in a new tab)
- 15 Mar · Board meeting
  Meeting on 15 Mar 2024
- 15 Mar · Board meeting
  With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 15th March, 2024 the date of closure .... (opens in a new tab)
- 6 Mar · Board meeting
  Meeting on 6 Mar 2024: rights issue
- 6 Mar · Board meeting
  Extension of issue closing date of Rights Issue from 07/03/2024 to 15/03/2024. (opens in a new tab)
Feb 2024
- 15 Feb · Board meeting
  Meeting on 15 Feb 2024
- 15 Feb · Board meeting
  Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in consultation .... (opens in a new tab)
- 1 Feb · Corporate action
  Intimation of Revised Record Date for issue of Equity Shares on Rights. (opens in a new tab)
Jan 2024
- 31 Jan · Board meeting
  Meeting on 31 Jan 2024: rights issue of equity shares and rights issue
- 31 Jan · Corporate action
  Intimation of Record Date. (opens in a new tab)
- 31 Jan · Board meeting
  Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in consultation .... (opens in a new tab)
- 20 Jan · Management
  Revised Intimation under Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 18 Jan · Corporate action
  Intimation of In-principle approval received for Rights Issue is attached herewith. (opens in a new tab)
- 12 Jan · Legal
  Clarification sought on significant movement in price (opens in a new tab)
- 12 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Keyur Dipakkumar Shah (opens in a new tab)
- 12 Jan · Legal
  Exchange has sought clarification from Dipna Pharmachem Ltd on January 11, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
- 4 Jan · Meeting
  Scrutinizer Report for Extraordinary General Meeting of 2023-24. (opens in a new tab)
- 3 Jan · Meeting
  Outcome of Extra Ordinary General Meeting held today i.e. 3rd January, 2024 in terms of the Regulations 30 of the SEBI(LODR) Regulations, 2015. (opens in a new tab)
- 1 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Keyur Dipakkumar Shah (opens in a new tab)
Dec 2023
- 27 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Keyur Dipakkumar Shah (opens in a new tab)
- 15 Dec · Board meeting
  Meeting on 15 Dec 2023
- 15 Dec · Management
  Appointment of Company Secretary (opens in a new tab)
- 15 Dec · Management
  Appointment Of Company Secretary (opens in a new tab)
- 15 Dec · Board meeting
  Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of .... (opens in a new tab)
- 15 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Keyur Dipakkumar Shah (opens in a new tab)
- 15 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipna Keyur Shah (opens in a new tab)
- 11 Dec · Meeting
  Notice of EGM to be held on Wednesday, 3rd January, 2024 (opens in a new tab)
- 11 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipna Keyur Shah (opens in a new tab)
- 8 Dec · Board meeting
  Meeting on 8 Dec 2023: increase in authorised capital
- 8 Dec · Board meeting
  We hereby inform you that meeting of the Board of Directors of the Company held today .... (opens in a new tab)
- 7 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipna Keyur Shah (opens in a new tab)
- 1 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipna Keyur Shah (opens in a new tab)
Nov 2023
- 28 Nov · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipna Keyur Shah (opens in a new tab)
- 3 Nov · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipna Keyur Shah (opens in a new tab)
Oct 2023
- 31 Oct · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipna Keyur Shah (opens in a new tab)
- 18 Oct · Results
  Submission of Unaudited Financial Results for the half year ended on 30th September, 2023 (opens in a new tab)

Dipna Pharmachem share news and announcements

Apr 2024

Mar 2024

Feb 2024

Jan 2024

Dec 2023

Nov 2023

Oct 2023